Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gh Research Plc (GHRS)

Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gh Research Plc JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN L2 D02 RY95 IRL

www.ghres.com P: 353-1437-8334

Description:

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is based in DUBLIN.

Key Statistics

Overview:

Market Capitalization, $K 582,193
Enterprise Value, $K 503,773
Shares Outstanding, K 52,028
Annual Sales, $ 0 K
Annual Net Income, $ -35,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,270 K
EBIT, $ -41,230 K
EBITDA, $ -40,910 K
60-Month Beta 0.80
% of Insider Shareholders 41.60%
% of Institutional Shareholders 56.90%
Float, K 30,384
% Float 58.40%
Short Volume Ratio 0.71

Growth:

1-Year Return 37.12%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 02/29/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -0.68
EPS Growth vs. Prev Qtr -90.91%
EPS Growth vs. Prev Year 34.38%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GHRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.48%
Return-on-Assets % -15.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.29
Book Value/Share 0.00
Interest Coverage -48.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar